LianBio Foreign Currency Transaction Gain (Loss), Unrealized
LianBio (LIANY) reported Foreign Currency Transaction Gain (Loss), Unrealized of $1.21 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2023-11-13
- LianBio foreign currency transaction gain (loss), unrealized for the quarter ending 2023-09-30 was -$55.00K, a 103.41% decline year-over-year.
- LianBio foreign currency transaction gain (loss), unrealized for the quarter ending 2023-06-30 was $1.20M.
- LianBio foreign currency transaction gain (loss), unrealized for the quarter ending 2023-03-31 was $66.00K, a 77.55% decline year-over-year.
- LianBio foreign currency transaction gain (loss), unrealized for the quarter ending 2022-12-31 was -$1.50M.
- LianBio foreign currency transaction gain (loss), unrealized for fiscal 2022 was -$127.00K.
- LianBio foreign currency transaction gain (loss), unrealized for fiscal 2021 was -$87.00K, a 122.89% decline from fiscal 2020.
- LianBio foreign currency transaction gain (loss), unrealized for fiscal 2020 was $380.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.14M derived: sum of 2 quarters · filed 2023-11-13 | $1.21M 10-Q · filed 2023-11-13 | -$296.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.26M 10-Q · filed 2023-08-14 | -$241.00K derived: sum of 3 quarters · filed 2023-08-14 | $1.37M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $66.00K 10-Q · filed 2023-05-11 | -$1.44M derived: sum of 2 quarters · filed 2023-05-11 | $179.00K derived: sum of 3 quarters · filed 2023-11-13 | -$355.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $113.00K derived: sum of 2 quarters · filed 2023-11-13 | -$421.00K derived: sum of 3 quarters · filed 2023-11-13 | -$127.00K 10-K · filed 2023-03-28 |
| 2022-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.08M derived: sum of 2 quarters · filed 2023-11-13 | $1.38M 10-Q · filed 2023-11-13 | $1.23M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$534.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$240.00K 10-Q · filed 2023-08-14 | -$383.00K derived: sum of 3 quarters · filed 2023-08-14 | -$373.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $294.00K 10-Q · filed 2023-05-11 | $151.00K derived: sum of 2 quarters · filed 2023-05-11 | $161.00K derived: sum of 3 quarters · filed 2023-05-11 | $141.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$133.00K derived: sum of 2 quarters · filed 2023-03-28 | -$153.00K derived: sum of 3 quarters · filed 2023-03-28 | -$87.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$10.00K derived: sum of 2 quarters · filed 2022-11-10 | $56.00K 10-Q · filed 2022-11-10 | $294.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $46.00K 10-Q · filed 2022-08-11 | $284.00K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | $66.00K 10-Q · filed 2022-05-12 | $304.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $238.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | $380.00K 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $142.00K 10-Q/A · filed 2022-01-10 |